Investigation of the relationship between hospitalization periods in patients with acute coronary syndrome

Aim: The aim of this study was to investigate the relationship between high sensitivity C-reactive protein (HsCRP), cardiac markers,D-dimer and brain natriuretic peptide (BNP) measured at admission to the emergency department in patients with acute coronarysyndrome (ACS).Material and Methods: In our clinic, patient records were scanned backwards. The records of the patients who presented to theemergency department with chest pain were evaluated. Patients with acute coronary syndrome were included in the study. Laboratoryvalues, echocardiogram and electrocardiograms of these patients were examined.Results: 88 patients with acute coronary syndrome were included in our study. According to the complaints of the patients, 93.2%(n=82) had chest pain, 45.5% (n=40) sweating, and 42% (n=37) had left arm pain at their admission to the emergency unit. The meanstick blood glucose value of the patients who came to our emergency department was 157±75.38 mg / dl (37.00-524.00 mg / dl).Biochemical laboratory values measured from venous blood taken at the time of arrival of patients, mean HsCRP 11.67±15.4 mg / l,insulin 14.87±29.53 IU / ml, glucose level 139.11±74.3 mg / dl, CK 426.9±12x8.9 mg / dl and CK-MB were determined as 41.1±46.8mg / dl.Conclusion: We conclude that there is no correlation between cardiac parameters, DDIM, glucose, insulin and HsCRP levels in thein-hospital prognosis and there is a relationship between the measured BNP levels and the length of hospital stay.

PDF

___

1. Tintinalli Judith E. Acute coronary syndromes: acute myocardial infarction and unstable angina. Emergency medicine 6st edition. McGraw Hill; Newyork; 2003. p. 343- 50.
2. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, et al. Myocardial infarction and coronary deaths in the World Health Organization Monica Project: Registiration procerdures, event rates, and case fatality rates in 38 populations from 21 countries in four continents. Circulation 1994;90:583- 612.
3. Task Force for Diagnosis and Treatment of Non-STSegment Elevation Acute Coronary Syndromes of European Society of Cardiology, Bassand JP, Hamm CW, Ardissino D, et al . Guidelines for the diagnosis and treatment of non-STsegment elevation acute coronary syndromes. Eur Heart J 2007:28:1598-1660.
4. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA Guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2000;36:970-1062.
5. Rogers WJ, Canto JG, Lambrew CT, et al: Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36:2056-2063.
6. Fibrinolytic Therapy Trialists’s (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and majör morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
7. Demiroglu IB, Demiroglu CC. Kalp Hastalıkları Tıbbi Tedavisi. 4. baskı. İstanbul; Güneş Tıp Kitabevi; 2000. p. 84-109.
8. Cusi K, Maezono K, Osman A, et al. Insulin resistance differentially affects the PI 3-kinase and MAP kinase mediated signaling in human muscle. J Clin İnvest 2000;105:311-20.
9. Hennekens CH. Increasing burden of cardiovascular disease. Current knowledge and future firections for research on risc factors. Circulation 1998;97:1095-102.
10. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. a report of the american college of cardiology/ american heart association task force on practice guidelines: committee on the management of patients with unstable angina. J Am Coll Cardiol 2000;36:970-1062.
11. Dündar ST, Yıldırmak S, Dündar C, ve ark. Akut koroner sendromlu hastalarda aspirin rezistansı. Türk Klinik Biyokimya Dergisi 2007:5:49-56.
12. Öngen Z. Akut koroner sendromlar: kavramı, sınıflaması, Risk düzeyi belirlemesi ve tedavi ilkeleri. Kardiyoloji Gündemi Sempozyum Dizisi. 2008:64:103-12.
13. Montoliu AT, Marin F, Roldan V, et al. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels. J Inter Med 2007;262:651-8.
14. Macdonald SPJ, Nagree Y. Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: A pilot study. Emerg Med Australas 2008;20:403-9.
15. Bogaty P, Boyer L, Simard S, et al. Clinical Utility of C-Reactive. JACC 2008;24:2339-46.
16. Scirica BM, Cannon CP, Sabatine MS, et al. Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death. Clin Chem 2009;55:265-73.
17. Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1264-72.
18. TIMI IIIA Investigators. Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit lesion in patients presenting with ischemic cardiac pain at rest: Results of the Thromboiysis in Myocardial Ischemia (TİMİ IIIA) trial. Circulation 1993;87:38-52.
19. Glezer MG, Syrkin AL, Gitel’ EP, et al. Acute coronary syndrome without elevation of the ST segment: prognostic significance of determining the levels of troponin I and CPKMBmass. Ter Arkh 2002;74:26-30.
20. Jernberg T, Stridsberg M, Venge P, et al. N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation. J Am Coll Cardiol 2002;40:437-45.
21. De Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001;345:1014-21.
22. Jaffery Z, Nowak R, Khoury N, et al. Myoglobin and troponin I elevation predict 5-year mortality in patients with undifferentiated chest pain in the emergency department. Am Heart J 2008;156:939-45.
23. Rathore S, Knowles P, Mann APS, et al. Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain. Eur J Inter Med 2008;19:537-40.
24. Barakett N, Ouaddour A, Lahidheb D, et al. Role of fibrin D-dimer in acute coronary syndrome. Prospective study of 22 cases. Tunis Med 2004; 82 (Suppl. 1):132-5.
25. Irmak R, Akın A, Tarakjı S, ve ark. Akut Koroner Sendromda Morbidite İle CRP Düzeyleri Arasındaki İlişki. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi 2005:1:13-6.
26. Liuzzo G, Biasucci LM, Gallimore JR. The prognostic value of Creactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994;331:417-24.
27. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-3.
28. Irmak R, Akın A, Tarakjı S, ve ark. Akut Koroner Sendromda Morbidite İle CRP Düzeyleri Arasındaki İlişki. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi 2005:1:13-6.
29. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.
30. Andersen TB, Ponitz V, Staines H, et al. The prognostic utility of D-dimer and fibrin monomer at longterm follow-up after hospitalization with coronary chest pain. Blood Coagul Fibrinolysis 2008;19:701-7.
31. Abdelmeguid AE, Topol EJ, Whitlow PL, et al. Significance of mild release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 1996;94:1528-36.
32. Brener SJ, Ellis SG, Schneider J. Frequency and long-term impact of myonecrosis after coronary stenting. Eur Heart J 2002;23:869-76.